Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Codman Neuro receives CE Mark clearance for enhanced Revive Se clot removal device

Codman Neuro, a part of DePuy Synthes Companies of Johnson & Johnson, has received CE Mark clearance for its Revive Se, the next generation self-expanding clot removal device for use in treating acute ischemic stroke.

The Revive Se device is a self-expanding nitinol basket that eases navigation through small and tortuous blood vessels and arteries in the cerebral vasculature, and allows quick restoration of blood flow to the brain when acute ischemic stroke occurs.

It features a closed-ended soft distal tip to capture clots and large fragments with minimal trauma, and a narrow and tall strut design to better penetrate and engage more clot.

This new strut design reduces the force needed to track the device through a 0.021 micro-catheter.

Germany’s University of Heidelberg neuroradiology department Martin Bendszus said that the ease of navigation is extremely important during a procedure like thrombectomy in terms of safety and time savings.

"The new device offers good navigation, and based on procedures with its predecessor device, provides consistently good recanalization rates and outcomes," Bendszus added.

Besides clot removal, clinicians can use the Rrevive Se devices for the non-surgical removal of emboli and thrombi, with aspiration and with the injection or infusion of contrast media and other fluids.

Currently, the device is not approved for distribution in the US.